SCHEMBL1663835

SCHEMBL1663835

O=C(Nc1ccc(-n2ncc3cc(Nc4ccc(N5CCC(O)CC5)cc4)ccc32)cc1)c1cnc2cc[nH]c2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPK10 P53779 5/20 0.40
MAPK8 P45983 4/20 0.40
ACKR3 P25106 1/20 0.40
TNIK Q9UKE5 1/20 0.40
ABL1 P00519 8/20 0.38
MAPK13 O15264 2/20 0.38
MAPK12 P53778 2/20 0.38
MAPK11 Q15759 2/20 0.38
MAPK14 Q16539 2/20 0.38
MAOB P27338 1/20 0.37
ABCB1 P08183 1/20 0.37
CYP3A4 P08684 1/20 0.37
CLK2 P49760 1/20 0.37
CLK3 P49761 1/20 0.37
DYRK1A Q13627 1/20 0.37
SYK P43405 1/20 0.37
NPC1 O15118 1/20 0.36
GAA P10253 1/20 0.36
MAPT P10636 1/20 0.36
RAB9A P51151 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1663837 0.94 ACKR3 (0.42) MAPK10MAPK8ACKR3TNIKABL1
SCHEMBL1665046 0.90 TNIK (0.44) MAPK10MAPK8TNIKMAPK13MAPK12
SCHEMBL6126148 0.89 MAPK10 (0.41) MAPK10MAPK8ACKR3TNIKABL1
SCHEMBL1665219 0.87 MAPK10 (0.43) MAPK10MAPK8TNIKABL1MAPK13
SCHEMBL6126205 0.86 NPC1 (0.40) MAPK10MAPK8TNIKABL1MAPK13
SCHEMBL1664303 0.85 MAPK10 (0.45) MAPK10MAPK8TNIKMAPK13MAPK12
SCHEMBL1665049 0.84 ESR1 (0.45) MAPK10MAPK8TNIKMAPK13MAPK12
SCHEMBL6126509 0.83 SMN1; SMN2 (0.45) MAPK10MAPK8TNIKABL1MAPK13
SCHEMBL1666461 0.83 MAPT (0.50) MAPK10MAPK8TNIKMAPK13MAPK12
SCHEMBL6126150 0.83 MAOB (0.42) MAPK10MAPK8ACKR3TNIKABL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2642994-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS Ligand Pharmaceuticals Incorporated (US) 2013-10-02 EP disclosed
EP-2488486-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES Ligand Pharmaceuticals Inc. (US) 2012-08-22 EP disclosed
WO-2012068406-A2 USE OF HEMATOPOIETIC GROWTH FACTOR MIMETICS LIGAND PHARMACEUTICALS INCORPORATED (US) 2012-05-24 WO disclosed
WO-2011046954-A1 HEMATOPOIETIC GROWTH FACTOR MIMETIC SMALL MOLECULE COMPOUNDS AND THEIR USES LIGAND PHARMACEUTICALS INC. (US) 2011-04-21 WO disclosed